(Q33746885)

29 July 2017

title

Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer (English)

1 reference

29 July 2017

1 reference

Hong Suk Song

1

1 reference

29 July 2017

Young Rok Do

2

1 reference

29 July 2017

In Ho Kim

3

1 reference

29 July 2017

Soo Sang Sohn

4

1 reference

29 July 2017

Kun Young Kwon

5

1 reference

29 July 2017

publication date

31 August 2004

1 reference

Cancer Research and Treatment

29 July 2017

published in

1 reference

29 July 2017

volume

36

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

240-245

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

29 July 2017

copyright license

start time

31 August 2004

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843891

DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis

30 October 2018

1 reference

12 December 2020

Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer

1 reference

12 December 2020

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

1 reference

12 December 2020

Clinical significance of epidermal growth factor receptor content in gastric cancer

1 reference

12 December 2020

Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells

1 reference

12 December 2020

Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer

1 reference

12 December 2020

Increased estrogen receptor and epidermal growth factor receptor gene product co-expression in surgically resected gastric adenocarcinomas

1 reference

12 December 2020

erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection

1 reference

12 December 2020

Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer

1 reference

12 December 2020

Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue

1 reference

12 December 2020

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

10.4143/CRT.2004.36.4.240

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference